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Abstract
Background: Recent studies have confirmed the existence of neuropathic pain (NeP) components in patients with
musculoskeletal disorders. However, the presence of NeP in patients with rotator cuff tears has not been
investigated thus far. Therefore, we studied the prevalence of NeP and the prognostic factors for NeP in
patients with rotator cuff tears.
Methods: Data were collected from 110 patients with rotator cuff tears, diagnosed by physical examination
and magnetic resonance imaging, who attended an outpatient clinic between August 2013 and August 2014.
The measured parameters included visual analog scale (VAS) pain scores, painDETECT questionnaire (PDQ) responses, a
physical examination, and magnetic resonance imaging. To evaluate the factors associated with NeP, we performed a
two-stage analysis. For univariate analysis, we used the Mann-Whitney U test. For multivariate analysis, forward stepwise
regression was performed using factors that demonstrated statistical significance in the univariate analysis.
Results: Patients were classified into three groups according to their PDQ score: an NeP group (n = 12; 10.9 %), possible
NeP group (n = 33; 30.0 %), and a nociceptive pain (NoP) group (n = 65; 59.1 %). In the univariate analysis
between the NeP group and NoP group, NeP was affected by sex (p = 0.034), VAS score (average pain during
the past 4 weeks; p = 0.013), and positive Neer and Hawkins impingement signs (p = 0.039). In the multivariate
analysis, VAS score (p = 0.031) was an independent prognostic factor for NeP.
Conclusions: Using the PDQ, we found that 10.9 % of patients with rotator cuff tears may have NeP. The
VAS score (average pain during the past 4 weeks) was a prognostic factor for NeP. Clinicians should remain
vigilant for heterogeneous etiologies of pain in patients with rotator cuff tears.
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Background
Rotator cuff tear is one of the major causes of pain and
dysfunction of the shoulder in the middle-aged popula-
tion. According to a recent epidemiological study, the
prevalence of rotator cuff tears was found to be 20.7 %
in the general population, with a mean age of 58 years
(range, 22–87 years), and increased with age [1]. Rota-
tor cuff tear can lead to persistent shoulder pain and
considerable disability. Although the pain caused by
rotator cuff tears is generally classified as nociceptive
pain (NoP), occasionally, it does not improve with
anti-inflammatory medication, and continued pain be-
comes the main surgical indication.
The primary etiology of pain in musculoskeletal disor-
ders is mechanical stimulation and inflammation [2].
However, recent studies have shown the clear existence of
neuropathic pain (NeP) components in patients with
chronic low back pain and knee osteoarthritis based on
responses to the painDETECT questionnaire (PDQ) [3, 4].
Recently, Gwilym et al. used the PDQ to detect NeP in
patients with impingement syndrome of the shoulder [5].
Correct identification of NeP in musculoskeletal disorders
enables the introduction of the appropriate treatment for
musculoskeletal pain. The PDQ is not only a simple and
efficient screening tool to identify the likelihood of NeP,
but also demonstrates higher sensitivity and specificity
than that of other screening tools for NeP [3, 6]. Clinicians
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are strongly recommended to use the PDQ to assess for
the presence of NeP [7]. However, the existence of NeP
in patients with rotator cuff tears has not been investi-
gated thus far. Therefore, the aim of this study was to
examine the prevalence of NeP in patients with rotator
cuff tears using the PDQ, and to elucidate the factors
associated with NeP. We hypothesized that the etiology
of shoulder pain in patients with rotator cuff tears may
be multifactorial, with a mixture of nociceptive and
neuropathic components.
Methods
This study was conducted in accordance with applicable
laws and regulations, including the guidelines of the
Declaration of Helsinki for human experimentation. All
patients provided written informed consent and the
protocol and informed consent forms were approved by
the local institutional review board (approval number:
1889). Two hospitals (KUH, KOH) participated in this
study and used the same protocol.
Inclusion and exclusion criteria
The inclusion criteria were as follows: patients with (1)
shoulder pain, and (2) rotator cuff tear on magnetic
resonance imaging (MRI) scan. The exclusion criteria were
as follows: (1) moderate or severe joint degeneration
according to the radiographic classification established by
Samilson and Prieto [8] and musculoskeletal abnormalities
including calcifying tendinitis on plain radiographs, (2) pain
with cervical motion and positive results on a Spurling test
or Jackson’s test during cervical spine examination [9, 10],
(3) history of central or peripheral nervous system lesions,
(4) diabetes mellitus, (5) prior surgery to the affected shoul-
der, (6) duration of symptoms less than 1 month or longer
than 60 months, (7) a workers’ compensation claim, and (8)
a history of medication use for NeP.
Patients who enrolled in this study were selected from
a source population of outpatients who attended one of
the two participating hospitals for the treatment of
shoulder pain between August 2013 and August 2014.
Clinical assessment consisted of a structured interview,
completion of the PDQ, a visual analog scale (VAS) for
pain, a detailed physical examination, plain radiographs,
and MRI scans. Among the 133 patients who met the
inclusion criteria, 23 patients were excluded, leaving 110
patients enrolled in the study (Fig. 1). Demographic data
and clinical features of the subjects, including age, sex,
history of trauma, duration of symptoms, and VAS pain
scores, are summarized in Table 1. All data were
collected prospectively and analyzed retrospectively.
PainDETECT questionnaire (PDQ)
The PDQ established by Freynhagen et al. [3, 11] was used
to identify the presence of NeP. The self-administered
questionnaire consists of 9 questions that address the
quality of NeP symptoms; no physical examination is
required. The first 7 questions address the gradation of
pain, and are scored from 0 to 5 (0 = never to 5 = very
strongly). Question 8 addresses the pain course pattern,
scored from –1 to 1, depending on which pain course
pattern diagram is selected. Question 9, for which the
response is “yes” or “no”, is scored as 2 or 0, respectively,
and addresses radiating pain (Table 2). The final score is
between –1 and 38 and indicates the likelihood of a
neuropathic component. A score of ≤ 12 indicates a low
likelihood of a neuropathic component (NoP group), while
a score of ≥ 19 suggests a high likelihood of a neuropathic
component (NeP group). A score between these values
indicates the possibility of a neuropathic component.
The Japanese version of the PDQ has been validated,
and has good reliability and validity according to a study
by Matsubayashi et al. [7]. The study included patients
with neuropathic pain related to the following patholo-
gies: brachial plexus injury (12 patients), radiculopathy
(12 patients), herpes zoster (11 patients), spinal cord in-
jury (10 patients), diabetic or alcoholic polyneuropathies
Fig. 1 Flow chart showing the number of patients enrolled,
according to our inclusion and exclusion criteria
Table 1 Demographic data and clinical features of the subjects
a(n = 110)
Age (y) 65.7 ± 8.5 (46–88)
Sex (male/female)b 60 (54.5)/50 (45.5)
History of traumab 47 (42.7)
Duration of symptoms (months) 9.9 ± 14.2 (1–60)
Visual analog scale score
Pain at the initial visit (points) 5.3 ± 2.8 (0–10)
Most severe pain during the past 4 weeks (points) 7.4 ± 2.6 (0–10)
Average pain during the past 4 weeks (points) 5.6 ± 2.6 (0–10)
aValues are expressed as mean ± SD (range)
bValues are expressed as number of patients (%)
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(7 patients), phantom pain (5 patients), complex regional
pain syndrome (CRPS; 2 patients), carpal tunnel syn-
drome (1 patient), and thalamic pain (1 patient) [7]. The
intraclass correlation coefficient for test–retest reliability
was 0.94, and Cronbach’s alpha for the total score and
main component were 0.78 and 0.80, respectively [7].
VAS for pain
The VAS, with a range from 0 to 10 (0 = no pain to 10 =
worst possible pain), was used to evaluate the current
pain experienced at the initial visit, the most severe pain
experienced during the past 4 weeks, and the average
pain experienced during the past 4 weeks.
Physical examination
Range-of-motion assessment included the measurement
of forward elevation, lateral/scapular elevation, external
rotation with the arm at the patient’s side, and internal
rotation behind the back, which was recorded as the
highest vertebral spinous process attained. Manual
muscle tests for strength and Neer and Hawkins
impingement tests were performed, as well as supraspi-
natus [12], infraspinatus [13], lift-off [14, 15], belly-press
[14, 15], and Speed tests to evaluate the rotator cuff and
biceps. All patients were evaluated at the initial visit.
Radiographic evaluation
Anteroposterior and axillary (West Point) radiographs
and MRI scans were obtained for all symptomatic
shoulders.
The size of the rotator cuff tear was established based
on the extent of the tear in the anteroposterior direction
as measured in a sagittal oblique plane on T2-weighted
MRI. Tears were then classified into 5 grades: partial
(articular-sided, bursal-sided, and intratendinous tears),
small (<1 cm), medium (≥ 1 cm and < 3 cm), large (≥
3 cm and < 5 cm), and massive (≥ 5 cm). When a fluid-
equivalent signal was visible or when the tendon could
not be visualized in at least one section of a fluid-
sensitive sequence, a full-thickness rotator cuff tear was
diagnosed. MRI studies were also evaluated to assess the
specific location of the rotator cuff tear. The presence of
fluid in the glenohumeral joint and subacromial space
was also evaluated in the coronal oblique plane on T2-
weighted MRI to detect hydrarthrosis.
Statistical analysis
To assess the association between pairs of qualitative
variables, we used the Mann-Whitney U test for univari-
ate analysis. For multivariate analysis, logistic regression
with a forward stepwise technique was performed using
factors that demonstrated statistical significance in the
univariate analysis. A P value of < 0.05 was considered sta-
tistically significant. Power analyses were performed with
EZR (Saitama Medical Center, Jichi Medical University,
Saitama, Japan) [16], which is a graphical user interface




Twelve patients (10.9 %) were classified into the NeP
group (score ≥ 19), 33 patients (30.0 %) into the possible
NeP group (score 13 to 18), and 65 patients (59.1 %) into
the NoP group (score ≤ 12) (Table 3).
Demographic data and clinical features
In the univariate analysis between the NeP group and
NoP group, the female-to-male ratio was significantly
higher in the NeP group than in the NoP group (p = 0.034),
Table 2 The painDETECT questionnaire
Item Score
Gradation of paina
Do you suffer from a burning sensation (e.g. stinging nettles)
in the marked areas?
0–5
Do you have a tingling or prickling sensation in the
area of your pain (like crawling ants or electrical tingling)?
0–5
Is light touching (clothing, a blanket) in this area painful? 0–5
Do you have sudden pain attacks in the area of your
pain, like electric shocks?
0–5
Is cold or heat (bath water) in this area occasionally painful? 0–5
Do you suffer from a sensation of numbness in the areas
that you marked?
0–5




Please select the picture that best describes the course
of your pain:
Persistent pain with slight fluctuations 0
Persistent pain with pain attacks –1
Pain attacks without pain between them +1
Pain attacks with pain between them +1
Radiating pain
Does your pain radiate to other regions of your body? Yes/No +2/0
aFor each question: never, 0; hardly noticed, 1; slightly, 2; moderately, 3; strongly,
4; very strongly, 5
Table 3 PainDETECT scores




On the basis of the responses to the painDETECT questionnaire, neuropathic
pain is likely with a score ≥ 19, possible with a score from 13 to 18, and
unlikely if the score is ≤ 12
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and the mean VAS score (average pain during the past
4 weeks) was significantly higher in the NeP group
than in the NoP group (p = 0.013). Other demographic
data, including age, history of trauma, and duration of
symptoms, did not differ significantly between the
groups (Table 4).
Physical examination
In the univariate analysis, the number of positive results
for the Neer and Hawkins impingement tests was signifi-
cantly higher in the NeP group (100 % [12 of 12]) than
in the NoP group (71.2 % [47 of 65]; p = 0.039). Other
physical examination results, including the supraspina-
tus, infraspinatus, lift-off, and belly press tests, did not
differ significantly between the groups (Table 4).
Radiographic evaluation
In the univariate analysis, radiographic findings, includ-
ing hydrarthrosis, tear location, and rotator cuff tear size
did not differ significantly between the groups (Table 4).
Multivariate analysis
In the multivariate analysis using logistic regression, we
included variables that demonstrated statistical signifi-
cance in the univariate analysis, specifically VAS score
(average pain during the past 4 weeks), sex, and the results
of the Neer and Hawkins impingement tests. The VAS
score (average pain during the past 4 weeks) was found to
be an independent prognostic factor for NeP (p = 0.031)
whereas NeP was not affected by sex or the results of the
Neer and Hawkins impingement tests (Table 5).






Age (y) 70.3 ± 8.9 (58–88) 65.5 ± 8.1 (46–83) 0.117
Sex (male/female)b 3 (25.0)/9 (75.0) 38 (58.5)/27 (41.5) 0.034*
History of traumab 5 (41.7) 30 (46.2) 0.776
Duration of symptoms (months) 11.3 ± 16.5 (1–60) 9.7 ± 13.5 (1–60) 0.439
Visual analog scale score
Pain at the initial visit (points) 6.5 ± 2.1 (3–9) 4.6 ± 3.0 (0–10) 0.051
Most severe pain during the past 4 weeks (points) 8.2 ± 1.9 (5–10) 6.8 ± 3.0 (0–10) 0.161
Average pain during the past 4 weeks (points) 6.8 ± 1.2 (5–9) 4.8 ± 2.6 (0–10) 0.013*
Positive Neer and/or Hawkins impingement testsb 12 (100) 47 (71.2) 0.039*
Positive supraspinatus testb 11 (91.7) 51 (78.5) 0.292
Positive infraspinatus testb 3 (25.0) 14 (21.5) 0.792
Positive lift-off and/or belly-press testsb 2 (16.7) 9 (13.8) 0.562
Hydrarthrosisb 8 (66.7) 39 (60.0) 0.666
Size of rotator cuff tearb
Partial
articular-sided 2 (16.7) 2 (3.1) 0.053
bursal-sided 3 (25.0) 6 (9.2) 0.121
intratendinous 1 (8.3) 5 (7.7) 0.934
Small (< 1 cm) 0 (0) 9 (13.8) 0.173
Medium (≥ 1 cm, < 3 cm) 3 (25.0) 27 (41.5) 0.284
Large (≥ 3 cm, < 5 cm) 3 (25.0) 10 (15.4) 0.417
Massive (≥ 5 cm) 0 (0) 6 (9.2) 0.276
Tear locationb
Supraspinatus 12 (100) 64 (98.5) 0.667
Infraspinatus 4 (33.3) 21 (32.3) 0.945
Subscapularis 3 (25.0) 14 (21.5) 0.792
*Statistically significant difference between the groups (p < 0.05)
aValues are expressed as mean ± SD (range)
bValues are expressed as number of patients (%)
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Discussion
To our knowledge, this is the first study to utilize the
PDQ in patients with shoulder pain attributed to rotator
cuff tears. We found that 10.9 % of patients with rotator
cuff tears may have NeP. Multivariate analysis revealed
that a higher VAS score for average pain during the past
4 weeks was significantly associated with the develop-
ment of NeP. Therefore, clinicians should remain
vigilant for heterogeneous etiologies of pain in patients
with rotator cuff tears.
There are some pharmacotherapy guidelines for NeP
[17–20]. Antidepressants and calcium channel alpha 2-
delta ligands are recommended as first-line therapy.
Therefore, the diagnosis of NeP in patients with a
rotator cuff tear is essential for optimal treatment. The
clinical outcomes of pharmacotherapy for these patients
needs to be elucidated.
Freynhagen et al. conducted a multicenter study and
found that 37 % of 7772 patients with various forms of
chronic low back pain exhibited pain that was predomin-
antly related to an NeP component [3]. Subsequently, NeP
has been reported to exist in 15 to 37.9 % of patients with
low back pain on the basis of their PDQ responses [21–25].
The pathology of NeP in patients with low back pain has
been attributed to nerve tissue damage generated by
mechanical compression or inflammation of the nerve root
due to degenerative disc disease [11]. Results from studies
in animal models have also suggested that factors such as
notch signaling activation [26], transient receptor potential
ankyrin 1 (TRPA1) [27], and Cdh1 [28] are involved in the
pathogenesis of NeP.
The PDQ has also been used to identify NeP in
patients with musculoskeletal disorders such as knee
osteoarthritis. NeP has been reported to exist in 5.4 to
32 % of patients with knee osteoarthritis on the basis of
their responses to the PDQ [4, 29–32]. The mechanism
of NeP in osteoarthritis remains unclear, but structural
changes of the joint and changes in pain processing of
the central nervous system have been implicated [33]. In
a mono-iodoacetate-induced knee osteoarthritis study in
rats, Orita et al. reported that the initial inflammatory
pain state, induced by local inflammation, was followed
by the gradual initiation of neuronal injury, which may
have contributed to the development of NeP [34].
The pathogenesis of NeP in patients with rotator cuff
tears remains unclear. There are neural mechanorecep-
tors such as Pacinian corpuscles, Ruffini endings, and
Golgi tendon organs, as well as nociceptors such as free
nerve endings in torn rotator cuff tissue and in the suba-
cromial bursa. In the shoulder, these mechanoreceptors
and nociceptors are mainly innervated by the suprascap-
ular nerve (C5) [35]. Inflammation caused by rotator
cuff tears may trigger injury of the neural mechanore-
ceptors and suprascapular nerve, thus leading to the
gradual development of NeP. Further analysis of the
interaction between rotator cuff tears and NeP is
required to clarify the etiology of NeP in patients with
rotator cuff tears.
This study has several limitations. First, the reliability of
the PDQ for identifying NeP in patients with rotator cuff
tears has not been assessed thus far. However, the original
validation study included a large sample (n = 411) of
patients with chronic pain who were recruited from 10
specialized pain centers [3]. The Japanese version of the
PDQ has shown excellent test-retest reliability (intraclass
correlation coefficient > 0.93) and good internal consistency
(Cronbach’s alpha ≥ 0.78) [7]. Furthermore, the PDQ dem-
onstrated excellent criterion validity when compared to an
expert pain physician as the reference standard, as indicated
by a high sensitivity, specificity, and positive predictive
value (all > 80 %) [3]. Second, adequate statistical power to
evaluate the outcomes was lacking because of the small
number of patients in the study sample. According to the
power analysis (type I error probability [a] = .05), the statis-
tical power in this study was 0.703 (VAS score; average pain
during the past 4 weeks), which is comparatively low.
Therefore, the probability of a type I error is limited.
Despite these limitations, we believe that the results of this
study can be helpful to clinicians when treating patients
with shoulder pain related to rotator cuff tears.
Conclusions
By using the PDQ, we found that 10.9 % of patients with
rotator cuff tears may experience NeP. Furthermore, we
found that VAS score (average pain during the past
4 weeks) was a prognostic factor for NeP in these
patients. This is a novel approach to an important sub-
ject and will hopefully encourage future research on the
topic of neuropathic shoulder pain in patients with rota-
tor cuff tears, as there is currently a paucity of informa-
tion. We believe that the creation of an animal model
with NeP and rotator cuff tears is needed to clarify the
etiology of NeP in patients with rotator cuff tears. Our
results indicate that clinicians should remain vigilant for
heterogeneous etiologies of pain in patients with rotator
cuff tears.
Table 5 Clinical factors associated with neuropathic pain
according to multivariate analysis using logistic regression
Independent variable Exp 95 % CI p-value
Sex 3.871 0.853–17.569 0.079
Visual analog scale pain score
Average pain during the past
4 weeks
0.674 0.471–0.964 0.031*
Positive Neer and/or Hawkins
impingement tests
- 0.989
*Statistically significant difference (p < 0.05)
Karasugi et al. BMC Musculoskeletal Disorders  (2016) 17:451 Page 5 of 6
Abbreviations
MRI: Magnetic resonance imaging; NeP: Neuropathic pain; NoP: Nociceptive
pain; PDQ: painDETECT questionnaire; VAS: Visual analog scale
Acknowledgments
The authors acknowledge Ken Kikuchi, PhD, for his help with the statistical
analysis.
Funding
The authors declare that there were no sources of funding for the research.
Availability of data and materials
The dataset supporting the conclusions of this article is available through the
corresponding author.
Authors’ contributions
TK and JI designed the study protocol. TK, JI, TK, and TT participated in the
acquisition of data. TK performed the statistical analysis, managed the literature
searches, summarized the previous related work, and wrote the first draft of the
manuscript. JI, NO, and HM provided critical revision for intellectual content and
final approval of the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All patients provided written informed consent and the protocol and
informed consent forms were approved by the local institutional review
board (approval number: 1889).
Author details
1Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto
University, 1-1-1, Honjo, Central Ward, Kumamoto City 860-8556, Japan.
2Department of Advanced Joint Reconstructive Surgery, Kumamoto
University Hospital, Kumamoto University, 1-1-1, Honjo, Central Ward,
Kumamoto City 860-8556, Japan. 3Kumamoto Orthopaedic Hospital, 1-15-7,
Kuhonji, Central Ward, Kumamoto City 862-0976, Japan.
Received: 12 April 2016 Accepted: 26 October 2016
References
1. Yamamoto A, Takagishi K, Osawa T, Yanagawa T, Nakajima D, Shitara H, et
al. Prevalence and risk factors of a rotator cuff tear in the general
population. J Shoulder Elbow Surg. 2010;19:116–20.
2. Clauw DJ. Diagnosing and treating chronic musculoskeletal pain based on
the underlying mechanism(s). Best Pract Res Clin Rheumatol. 2015;29:6–19.
3. Freynhagen R, Baron R, Gockel U, Tölle TR. painDetect: a new screening
questionnaire to identify neuropathic components in patients with back
pain. Curr Med Res Opin. 2006;22:1911–20.
4. Ohtori S, Orita S, Yamashita M, Ishikawa T, Ito T, Shigemura T, et al.
Existence of a neuropathic pain component in patients with osteoarthritis
of the knee. Yonsei Med J. 2012;53:801–5.
5. Gwilym SE, Oag HC, Tracey I, Carr AJ. Evidence that central sensitisation is
present in patients with shoulder impingement syndrome and influences
the outcome after surgery. J Bone Joint Surg (Br). 2011;93:498–502.
6. Mathieson S, Lin C. painDETECT questionnaire. J Physiother. 2013;59:211.
7. Matsubayashi Y, Takeshita K, Sumitani M, Oshima Y, Tonosu J, Kato S, et al.
Validity and reliability of the Japanese version of the painDETECT
questionnaire: a multicenter observational study. PLoS One. 2013;8:e68013.
8. Samilson RL, Prieto V. Dislocation arthropathy of the shoulder. J Bone Joint
Surg Am. 1983;65:456–60.
9. Jackson R. The classic: the cervical syndrome. 1949. Clin Orthop Relat Res.
2010;468:1739–45.
10. Spurling RG, Scoville WB. Lateral rupture of the cervical intervertebral discs: a
common cause of shoulder and arm pain. Surg Gynecol Obstet. 1944;78:350–8.
11. Freynhagen R, Baron R. The evaluation of neuropathic components in low
back pain. Curr Pain Headache Rep. 2009;13:185–90.
12. Jobe FW, Jobe CM. Painful athletic injuries of the shoulder. Clin Orthop
Relat Res. 1983;173:117–24.
13. Hama H, Morinaga T, Suzuki K, Kuroki H, Sunami M, Yamamuro T. The
infraspinatus test: An early diagnostic sign of muscle weakness during external
rotation of the shoulder in athletes. J Shoulder Elbow Surg. 1993;2:257–9.
14. Gerber C, Hersche O, Farron A. Isolated rupture of the subscapularis tendon.
J Bone Joint Surg Am. 1996;78:1015–23.
15. Ide J, Tokiyoshi A, Hirose J, Mizuta H. Arthroscopic repair of traumatic
combined rotator cuff tears involving the subscapularis tendon. J Bone
Joint Surg Am. 2007;89:2378–88.
16. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for
medical statistics. Bone Marrow Transplant. 2013;48:452–8.
17. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, et al.
EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J
Neurol. 2006;13:1153–69.
18. Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et
al. Pharmacologic management of neuropathic pain: evidence-based
recommendations. Pain. 2007;132:237–51.
19. Tan T, Barry P, Reken S, Baker M. Guideline Development Group.
Pharmacological management of neuropathic pain in non-specialist
settings: summary of NICE guidance. BMJ. 2010;340:c1079.
20. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS
guidelines on the pharmacological treatment of neuropathic pain: 2010
revision. Eur J Neurol. 2010;17:1113–e88.
21. Beith ID, Kemp A, Kenyon J, Prout M, Chestnut TJ. Identifying neuropathic
back and leg pain: a cross-sectional study. Pain. 2011;152:1511–6.
22. Hiyama A, Watanabe M, Katoh H, Sato M, Sakai D, Mochida J. Evaluation of
quality of life and neuropathic pain in patients with low back pain using
the Japanese Orthopedic Association Back Pain Evaluation Questionnaire.
Eur Spine J. 2015;24:503–12.
23. Morsø L, Kent PM, Albert HB. Are self-reported pain characteristics, classified
using the PainDETECT questionnaire, predictive of outcome in people with
low back pain and associated leg pain? Clin J Pain. 2011;27:535–41.
24. Schmidt CO, Schweikert B, Wenig CM, Schmidt U, Gockel U, Freynhagen R,
et al. Modelling the prevalence and cost of back pain with neuropathic
components in the general population. Eur J Pain. 2009;13:1030–5.
25. Sakai Y, Ito K, Hida T, Ito S, Harada A. Neuropathic pain in elderly patients
with chronic low back pain and effects of pregabalin: a preliminary study.
Asian Spine J. 2015;9:254–62.
26. Xie K, Qiao F, Sun Y, Wang G, Hou L. Notch signaling activation is critical to
the development of neuropathic pain. BMC Anesthesiol. 2015;15:41.
27. Miyakawa T, Terashima Y, Takebayashi T, Tanimoto K, Iwase T, Ogon I, et al.
Transient receptor potential ankyrin 1 in spinal cord dorsal horn is involved
in neuropathic pain in nerve root constriction rats. Mol Pain. 2014;10:58.
28. Tan W, Yao WL, Hu R, Lv YY, Wan L, Zhang CH, et al. Alleviating neuropathic
pain mechanical allodynia by increasing Cdh1 in the anterior cingulate
cortex. Mol Pain. 2015;11:56.
29. Hochman JR, French MR, Bermingham SL, Hawker GA. The nerve of
osteoarthritis pain. Arthritis Care Res (Hoboken). 2010;62:1019–23.
30. Hochman JR, Gagliese L, Davis AM, Hawker GA. Neuropathic pain symptoms
in a community knee OA cohort. Osteoarthritis Cartilage. 2011;19:647–54.
31. das Moreton BJ, Tew V, Nair R, Wheeler M, Walsh DA, Lincoln NB. Pain
phenotype in patients with knee osteoarthritis: classification and
measurement properties of painDETECT and self-report Leeds assessment of
neuropathic symptoms and signs scale in a cross-sectional study. Arthritis
Care Res (Hoboken). 2015;67:519–28.
32. Roubille C, Raynauld JP, Abram F, Paiement P, Dorais M, Delorme P, et al.
The presence of meniscal lesions is a strong predictor of neuropathic pain
in symptomatic knee osteoarthritis: a cross-sectional pilot study. Arthritis Res
Ther. 2014;16:507.
33. Sofat N, Ejindu V, Kiely P. What makes osteoarthritis painful? The evidence for
local and central pain processing. Rheumatology (Oxford). 2011;50:2157–65.
34. Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, et al. Pain-related
sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees
that gradually develops neuronal injury in addition to inflammatory pain.
BMC Musculoskelet Disord. 2011;12:134.
35. Vangsness Jr CT, Ennis M, Taylor JG, Atkinson R. Neural anatomy of the
glenohumeral ligaments, labrum, and subacromial bursa. Arthroscopy.
1995;11:180–4.
Karasugi et al. BMC Musculoskeletal Disorders  (2016) 17:451 Page 6 of 6
